Analysis of Pyrimidine Synthesis “de Novo” Intermediates in Urine and Dried Urine Filter- Paper Strips with HPLC–Electrospray Tandem Mass Spectrometry

Abstract

Background:The concentrations of the pyrimidine "de novo" metabolites and their degradation products in urine are useful indicators for the diagnosis of an inborn error of the pyrimidine de novo pathway or a urea-cycle defect. Until now, no procedure was available that allowed the analysis of all of these metabolites in a single analytical run. We describe a rapid, specific method to measure these metabolites by HPLC-tandem mass spectrometry. Methods: Urine or urine-soaked filter-paper strips were used to measure N-carbamyl-aspartate, dihydroorotate, orotate, orotidine, uridine, and uracil. Reversed-phase HPLC was combined with electrospray ionization tandem mass spectrometry, and detection was performed by multiple-reaction monitoring. Stable-isotope-labeled reference compounds were used as internal standards. Results: All pyrimidine de novo metabolites and their degradation products were measured within a single analytical run of 14 min with lower limits of detection of 0.4 -3 mol/L. The intra-and interassay variation for urine with added compounds was 1.2-5% for urines and 2-9% for filter-paper extracts of the urines. Recoveries of the added metabolites were 97-106% for urine samples

Developing Urinary Metabolomic Signatures as Early Bladder Cancer Diagnostic Markers

“…Ureidosuccinic acid (or carbamoylaspartic acid) is an intermediary product in both aspartate and pyrimidine synthesis. Ureidosuccinic acid can be detected in urine (van Kuilenburg et al, 2004) and was previously reported to associated with prostate cancer progression (Sreekumar et al, 2009). Our data also found concentration alteration of two tetrapeptides (GlyCysAlaLys and AspAspGlyTrp) in urine of BCa patients.…”

Introduction of a Fluorine Atom at C3 of 3-Deazauridine Shifts Its Antimetabolic Activity from Inhibition of CTP Synthetase to Inhibition of Orotidylate Decarboxylase, an Early Event in the de Novo Pyrimidine Nucleotide Biosynthesis Pathway

“…Concentrations of the pyrimidine nucleoside metabolites and their degradation products that eluted from the Partisil-SAX HPLC column within 4 min were determined using HPLC tandem mass spectrometry, essentially as described before (14). period, the cell extracts were prepared and subjected to HPLC analysis as described above.…”

“…CEM cell extracts were then exposed to the 3F-3DUrd 5Ј-monophosphate, and [ 14 14 C]OA (ϳ5-fold more UMP than OMP was formed at each time point). In the presence of K-oxonate, OMP was detected only in trace amounts, and UMP was virtually undetected (Fig.…”

Application of the dried spot sampling technique for rat cerebrospinal fluid sample collection and analysis

“…A 3-5 mm punch is taken from the sample spot, the analytes are removed by liquid extraction, and the extracts are analyzed by conventional bioanalytical techniques. The benefits of the approach for sampling plasma and urine have been discussed in detail [3][4][5][6][7][8]. Study costs in toxicological species can be significantly reduced because the small volumes sampled eliminates the need for satellite TK groups.…”